Skip to content

Emulsion Droplet Physical State on Postprandial Lipemia and Satiety

Impact of Emulsion Droplet Physical State on Postprandial Lipemia and Satiety in Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03515590
Enrollment
15
Registered
2018-05-03
Start date
2018-07-02
Completion date
2019-12-31
Last updated
2020-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial Lipemia, Satiety

Brief summary

The purpose of this study is to compare the changes in blood lipids and feelings of satiety after consumption of oil-in-water emulsions in which the droplets are in either the liquid or solid (i.e. crystalline) states.

Detailed description

A double blinded randomized cross-over acute meal study will be carried out in which 15 healthy male participants will attend two study visits, separated by at least one week. On each study visit, fasted participants will consume either the solid or the liquid emulsion, in a randomized order. Both emulsions tested will have the exact same composition only differing in the physical state of the lipid emulsions, in order to isolate the impact of physical state, specifically, on metabolic response. Postprandial lipemia and satiety will be measured for 6 hours after consumption of the test beverage. The study meals will include crushed acetominophen, the appearance of which will be measured in plasma as a measure of liquid content gastric emptying. Participants will be asked to maintain their usual lifestyle habits throughout the study, with some changes in the 48 hour period leading up to each of the two visits.

Interventions

OTHEREmulsion with solid droplets

This will be a 500 mL beverage emulsion in which the droplets are crystalline. It will have identical composition to the other intervention, i.e. in one the lipid droplets are solid (i.e. crystallized) and the other in which they remain liquid will be introduced at least 7 days apart. The differences in physical state will be achieved simply by changing the temperatures the emulsions are held at. The emulsion will contain 10 % of the lipid palm stearin with 0.4% of the emulsifier sorbitan monostearate (Span60).

OTHEREmulsion with liquid droplets

This will be a 500 mL beverage emulsion in which the droplets are liquid. It will have identical composition to the other intervention, i.e. in one the lipid droplets are solid (i.e. crystallized) and the other in which they remain liquid will be introduced at least 7 days apart. The differences in physical state will be achieved simply by changing the temperatures the emulsions are held at. The emulsion will contain 10 % of the lipid palm stearin with 0.4% of the emulsifier sorbitan monostearate (Span60).

Sponsors

University of Guelph
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI of 18 - 26 kg/m2 * generally healthy * non-smoking * non to moderate alcohol drinkers * fasting plasma cholesterol level \<5.2 mmol/L * plasma triacylglycerol level \<1.7 mmol/L * plasma glucose level \<5.6 mmol/L

Exclusion criteria

* History of major medical conditions * taking prescription medications/ over the counter medications * taking natural health products/ dietary supplements (other than a multivitamin) * oral antibiotic use in the previous 3 months * planning to take oral antibiotics in the next 3 months * food allergy/anaphylactic/life-threatening allergy * smokers/ regular users of recreational drugs * elite/ training athletes * significant weight loss/ gain during the past 3 months * previous reaction/ sensitivity to acetaminophen * inability to avoid taking acetaminophen for 48 hours * sensitivity to the artificial sweetener Sugar Twin® Sucralose and artificial vanilla extract * not willing to consume Sugar Twin® Sucralose or Artificial vanilla.

Design outcomes

Primary

MeasureTime frameDescription
Triacylglycerols6 hoursFasting and postprandial blood sample analysis

Secondary

MeasureTime frameDescription
Gastric emptying6 hoursThe rate of appearance of acetaminophen (consumed crushed in water immediately after test meal) in the plasma will be determined.
Cholecystokinin6 hoursFasting and postprandial blood sample analysis
Satiety ratings6 hoursVisual analogue scale ratings of feelings of hunger, fullness, appetite, fatigue, after consuming the emulsion beverage. 0: not hungry, empty, no appetite and no fatigue and 10: very hungry, very full, can eat a lot and very fatigued. The distance from the left end of the scale will be measured.
Apolipoprotein B486 hoursFasting and postprandial blood sample analysis
Chylomicron size6 hoursFasting and postprandial blood sample analysis
Fatty acid composition6 hoursFasting and postprandial blood sample analysis

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026